CONICET-MPG Partner Institute Buenos Aires

CONICET-MPG Partner Institute Buenos Aires

About the Institute

The Biomedicine Research Institute of Buenos Aires – CONICET-Partner Institute of the Max Planck Society (IBioBA-MPSP) is run since the official inauguration in 2011 in cooperation with Argentina’s Council for Scientific and Technological Research (CONICET) in the frame of the cooperation between the MPS and the Argentine Ministry of Science, Technology and Innovation, and forms part of the new “Polo Científico” research campus. The project was primarily based on the more than 20 years-old cooperation between argentine and Max Planck scientist, particularly Professor Florian Holsboer, Director of the Max Planck Institute of Psychiatry in Munich, and Professor Eduardo Arzt who is the Founding Director of the Partner Institute and since 2005 an External Scientific Member of the Max Planck Institute of Psychiatry.

After several years of construction, since 2012 a new building of the “Polo Científico”, located on the former site of the well-known old winery Bodega Giol in the Palermo district of Buenos Aires, is housing the IBioBA.

Research priorities

The Institute’s primary goal and structure follows and promotes interdisciplinary research in molecular and cell biology with a particular focus on identifying the molecular basis of key physio- and pahological processes and mechanisms of chronic degenerative diseases and potential new treatments. To this end, the Institute incorporated scientists from several disciplines and with different expertise spanning from molecular modeling and chemical biophysics to molecular and cell biology and extended to animal genetics and physiology. The interdisciplinary approach is followed also in the cooperation with other research institutions located on the “Polo Científico”.

The IBioBA performs its research activities in close cooperation with Max Planck Institutes, current ongoing collaborations are particularly strong with the MPI for Biophysical Chemistry, Göttingen, the MPI for Heart and Lung Research, Bad Nauheim, and the MPI for Molecular Physiology, Dortmund.

In addition, the Institute will also be focusing on providing training, for example for post-docs, and attracting Argentinean scientists back from abroad. Until now the IBioBA has incorporated six argentine researchers repatriated from top centers overseas.

Go to Editor View